CARISSA WILKINS: Open Payments
NPI 1164926549 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 54 payments from 15 companies in 2025. Trend: 2023 $619 · 2024 $1,322 · 2025 $1,166
Food & beverage: $1,089Education: $77
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $206 |
| AstraZeneca Pharmaceuticals LP | 8 | $199 |
| GlaxoSmithKline, LLC. | 8 | $142 |
| Lilly USA, LLC | 7 | $130 |
| Astellas Pharma US Inc | 2 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| ABBVIE INC. | 4 | $71 |
| Amgen Inc. | 3 | $58 |
| PFIZER INC. | 2 | $48 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
Products named: Wegovy, TRELEGY ELLIPTA, JARDIANCE, REXULTI, AIRSUPRA, FARXIGA, REPATHA, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
